|
M.B. Antsiferov (1), V.V. Fadeev (2), T.B. Morgunova (2)
MODERN APPROACHES TO THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№16 / 2016
|
|
M.B. Antsiferov
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
|
№5 / 2016
|
|
M.B. Antsiferov (1), T.P. Nikitina (2), A.Yu. Rodionova (3), K.A. Kurbatova (2), T.I. Ionova (2)
HYPOGLYCEMIA AND QUALITY OF LIFE OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№17 / 2015
|
|
A.S. Ametov
ADVANTAGES OF FIXED COMBINATION OF SAXAGLIPTIN AND METFORMIN WITH MODIFIED RELEASE (KOMBOGLYCE PROLONG) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№5 / 2015
|
|
N.V. Zaitseva, M.Sh. Shamkhalova
COMBINATION THERAPY WITH GLIMEPIRIDE AND METFORMIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. THE RESULTS OF OBSERVATIONAL STUDIES
|
№16 / 2014
|
|
N.A. Petunina , I.A. Kuzina
METFORMIN - A RELIABLE PARTNER IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
M.Sh. Abaeva, P.K. Nazhmutdinova, A.S. Ametov
INFLUENCE METFORMIN AND VILDAGLIPTIN ON CARBOHYDRATE AND FAT METABOLISM IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
№5 / 2014
|
|
A.S. Ametov
ADVANTAGES OF THE NEW FIXED COMBINATION OF SAXAGLIPTIN AND TIME-RELEASE METFORMIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
|
№16 / 2013
|
|
I.Yu.Demidova, V. V. Boeva
EARLY DIAGNOSIS AND TREATMENT OF IMPAIRED FASTING GLUCOSE REDUCES RATE OF ITS CONVERSION TO IMPAIRED GLUCOSE TOLERANCE AND TYPE 2 DIABETES MELLITUS
|
№10 / 2013
|
|
N.A. Petunina, L.V. Trukhina, E.I. Sinitsina, M.B. Antsiferov
Benefits Of Long-acting Metformin
|
№5 / 2013
|
|
E.E.Arinina, M.A.Rasheed, M. B. Antsiferov
Pharmacoeconomic Analysis Of Advantages Of Combined Incretin Therapy In Patients With Type 2 Diabetes Mellitus By The Example Of Vildagliptin
|
№5 / 2013
|
|
I.N. Zakharova, MD, Prof.; S.V. Yablochkova
Metabolic Syndrome In Children: A Modern View On The Problem
|
№1 / 2013
|
Русский
